Cheuk Hong Leung - Concepedia

Author

Cheuk Hong Leung

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

C. Leung, C.H. Leung, Cheuk H Leung, Cheuk H. Leung, Cheuk Hong Leung, Cheuk Leung, Ching-Yu Roland Leung, Ching-Yu Roland Leung

122

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Beneficência Portuguesa de São Paulo The University of Texas Health Science Center at Houston

About

Cheuk Hong Leung is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	962
2	Health Sciences	1	1	20
3	Biochemistry	1	1	46
4	Biostatistics	1	1	15
5	Cell Biology	1	1	46

Cheuk Hong Leung

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial Tina Cascone, William N. William, Annikka Weissferdt, Nature Medicine Neostar TrialMedicineImmune Checkpoint InhibitorCancer TreatmentPhase 2	2021	582
Immuno-genomic landscape of osteosarcoma Chia-Chin Wu, Hannah C. Beird, J. Andrew Livingston, Nature Communications	2020	234
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt, Nature Medicine	2023	191
Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): Clinical and correlative results from the NEOSTAR study. Tina Cascone, William Nassib William, Annikka Weissferdt, Journal of Clinical Oncology Neostar StudySurgical OncologyImmunologyPathologyCorrelative Results	2019	142
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer Tina Cascone, Annikka Weissferdt, Myrna C. B. Godoy, Nature Communications	2021	102
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer Boris Sepesi, Nicolas Zhou, William N. William, Journal of Thoracic and Cardiovascular Surgery Surgical OncologyCell Lung CancerMedicineCancer ManagementImmune Checkpoint Inhibitor	2022	84
Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor Brian A. Menegaz, Branko Cuglievan, Jalen Benson, The Oncologist	2017	49
Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma Richa Rathore, Katharine E. Caldwell, Charles R. Schutt, Cell Reports Rapamycin Complex 1Metabolic RemodelingPro-survival Mtorc1Metabolic CompensationCancer Biology	2021	46
Risk factors for falls in older patients with cancer Xiaotao Zhang, Ming Sun, Suyu Liu, BMJ Supportive & Palliative Care	2017	44
Outcomes of systemic therapy in metastatic phyllodes tumor of the breast Amanda Parkes, Wei‐Lien Wang, Shreyaskumar Patel, Breast Cancer Research and Treatment Surgical OncologyBreast OncologyMedicineCancer ManagementPathology	2021	25

Page 1